Literature DB >> 28827449

Correction: Novel in vitro booster vaccination to rapidly generate antigen-specific human monoclonal antibodies.

Irene Sanjuan Nandin, Carol Fong, Cecilia Deantonio, Juan A Torreno-Pina, Simone Pecetta, Paula Maldonado, Francesca Gasparrini, Jose Ordovas-Montanes, Samuel W Kazer, Svend Kjaer, Daryl W Borley, Usha Nair, Julia A Coleman, Daniel Lingwood, Alex K Shalek, Eric Meffre, Pascal Poignard, Dennis R Burton, Facundo D Batista.   

Abstract

Entities:  

Year:  2017        PMID： 28827449      PMCID： PMC5584127          DOI： 10.1084/jem.2017063307262017c

Source DB:  PubMed          Journal:  J Exp Med        ISSN： 0022-1007            Impact factor:   14.307


× No keyword cloud information.
Vol. 214, No. 8, August, 2017. https://doi.org/10.1084/jem.20170633 JEM regrets that in the original online version of this paper, the graph in Fig. 6 c was incomplete as the result of a production error.
The corrected Fig. 6 appears below. All versions of this article have been corrected.
  3 in total

1.  Generation of Discriminative Human Monoclonal Antibodies from Rare Antigen-specific B Cells Circulating in Blood.

Authors:  Marie-Claire Devilder; Mélinda Moyon; Xavier Saulquin; Laetitia Gautreau-Rolland
Journal:  J Vis Exp       Date:  2018-02-06       Impact factor: 1.355

Review 2.  Insights From Analysis of Human Antigen-Specific Memory B Cell Repertoires.

Authors:  Hemangi B Shah; Kenneth Smith; Jonathan D Wren; Carol F Webb; Jimmy D Ballard; Rebecka L Bourn; Judith A James; Mark L Lang
Journal:  Front Immunol       Date:  2019-01-15       Impact factor: 7.561

3.  Production and characterization of Newcastle disease antibody as a reagent to develop a rapid immunodiagnostic test tool.

Authors:  Dwi Desmiyeni Putri; Ekowati Handharyani; Retno Damajanti Soejoedono; Agus Setiyono; Okti Nadia Poetri
Journal:  Vet World       Date:  2018-07-05
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.